Logo

American Heart Association

  2
  0


Final ID:

Discussant: VALOR-HCM

  • Deswal, Anita  ( Univ. of Texas MD Anderson Cancer Center , Bellaire , Texas , United States )
  • Ho, Jennifer  ( Harvard Medical School , Newton , Massachusetts , United States )
  • Ho, Carolyn  ( Carolyn Ho , Brookline , Massachusetts , United States )
  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
    Anita Deswal: DO have relevant financial relationships ; Consultant:Bayer (Any division):Active (exists now) | Jennifer Ho: DO have relevant financial relationships ; Individual Stocks/Stock Options:Pfizer:Active (exists now) | Carolyn Ho: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squib:Active (exists now) ; Consultant:viz.ai:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Research Funding (PI or named investigator):Biomarin:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now) ; Consultant:Bristol Myers Squib:Active (exists now) | Sharlene Day: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
Discussant: SCAN-MP

Alexander Kevin

Discussant: Danon Disease Phase 1 RP-A501

Gillmore Julian, Taylor Matthew, Adler Eric

More abstracts from these authors:
The Rings of Power: HFrEF Quadruple Therapy and AF

Bozkurt Biykem, Deswal Anita, Dunlay Shannon

Hypertrophic Cardiomyopathy

Day Sharlene

You have to be authorized to contact abstract author. Please, Login
Not Available